Citations (28)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Marco Onofrj, Danilo Carrozzino, Aurelio D’Amico, Roberta Di Giacomo, Stefano Delli Pizzi, Astrid Thomas, Valeria Onofrj, John-Paul Taylor & Laura Bonanni. (2017) Psychosis in parkinsonism: an unorthodox approach. Neuropsychiatric Disease and Treatment 13, pages 1313-1330.
Read now
Read now
Nafiseh Hashemi, Robert Asa Scranton, Maryam Hashemi & Andrew G Lee. (2012) Visual hallucinations: a review for ophthalmologists. Expert Review of Ophthalmology 7:5, pages 471-479.
Read now
Read now
Joseph H. Friedman, P. Agarwal, R. Alcalay, K. J. Black, K. L. Chou, L. Cote, P. Dayalu, S. Frank, J. Hartlein, R. A. Hauser, A. E. Lang, L. Marsh, F. Marshall, C. Moskowitz, B. Ravina, D. Riley, J. Sanchez-Ramos, D. K. Simon, T. Simuni, J. Sutton, P. Tuite, D. Weintraub & T. Zesiewicz. (2011) Clinical Vignettes in Parkinson's Disease: A Collection of Unusual Medication-Induced Hallucinations, Delusions, and Compulsive Behaviours. International Journal of Neuroscience 121:8, pages 472-476.
Read now
Read now
Articles from other publishers (25)
Wei Lin Toh, Caitlin Yolland, Caroline Gurvich, James Barnes & Susan L. Rossell. (2023) Non-visual hallucinations in Parkinson’s disease: a systematic review. Journal of Neurology 270:6, pages 2857-2889.
Crossref
Crossref
Farzad Salehpour, Saeed Sadigh-Eteghad, Javad Mahmoudi, Farzin Kamari, Paolo Cassano & Michael Richard HamblinFarzad Salehpour, Saeed Sadigh-Eteghad, Javad Mahmoudi, Farzin Kamari, Paolo Cassano & Michael Richard Hamblin. 2023. Photobiomodulation for the Brain. Photobiomodulation for the Brain
191
219
.
Jeffrey Kim, Etienne W. Daadi, Thomas Oh, Elyas S. Daadi & Marcel M. Daadi. (2022) Human Induced Pluripotent Stem Cell Phenotyping and Preclinical Modeling of Familial Parkinson’s Disease. Genes 13:11, pages 1937.
Crossref
Crossref
Cynthia Kwan & Philippe Huot. (2022) An overview of the active clinical trials for Parkinson’s disease psychosis. Neurodegenerative Disease Management 12:4, pages 165-170.
Crossref
Crossref
Aviv D. Mizrahi-Kliger, Lucia K. Feldmann, Andrea A. Kühn & Hagai Bergman. (2022) Etiologies of insomnia in Parkinson's disease – Lessons from human studies and animal models. Experimental Neurology 350, pages 113976.
Crossref
Crossref
Yanyan Zhang, Xiaoguang Zhang, Yunhua Yue & Tian Tian. (2022) Retinal Degeneration: A Window to Understand the Origin and Progression of Parkinson’s Disease?. Frontiers in Neuroscience 15.
Crossref
Crossref
Nicholas Murphy, Alison Killen, Rajnish Kumar Gupta, Sara Graziadio, Lynn Rochester, Michael Firbank, Mark R. Baker, Charlotte Allan, Daniel Collerton, John-Paul Taylor & Prabitha Urwyler. (2021) Exploring Bottom-Up Visual Processing and Visual Hallucinations in Parkinson's Disease With Dementia. Frontiers in Neurology 11.
Crossref
Crossref
Mirella Russo, Claudia Carrarini, Fedele Dono, Marianna Gabriella Rispoli, Martina Di Pietro, Vincenzo Di Stefano, Laura Ferri, Laura Bonanni, Stefano Luca Sensi & Marco Onofrj. (2019) The Pharmacology of Visual Hallucinations in Synucleinopathies. Frontiers in Pharmacology 10.
Crossref
Crossref
Cynthia Kwan & Philippe Huot. (2019)
5-HT
3
receptors in Parkinson’s disease psychosis: a forgotten target?
. Neurodegenerative Disease Management 9:5, pages 251-253.
Crossref
Crossref
Charlotte Louise Eversfield & Llwyd David Orton. (2018) Auditory and visual hallucination prevalence in Parkinson's disease and dementia with Lewy bodies: a systematic review and meta-analysis. Psychological Medicine 49:14, pages 2342-2353.
Crossref
Crossref
Danilo Carrozzino, Per Bech, Chiara Patierno, Marco Onofrj, Bo Mohr Morberg, Astrid Thomas, Laura Bonanni & Mario Fulcheri. (2017) Somatization in Parkinson's Disease: A systematic review. Progress in Neuro-Psychopharmacology and Biological Psychiatry 78, pages 18-26.
Crossref
Crossref
Florent Bernardin, Raymund Schwan, Laurence Lalanne, Fabienne Ligier, Karine Angioi-Duprez, Thomas Schwitzer & Vincent Laprevote. (2017) The role of the retina in visual hallucinations: A review of the literature and implications for psychosis. Neuropsychologia 99, pages 128-138.
Crossref
Crossref
Muhammad Adnan KhanSyed A. QuadriHassaan Tohid. (2017) A comprehensive overview of the neuropsychiatry of Parkinson's disease: A review. Bulletin of the Menninger Clinic 81:1, pages 53-105.
Crossref
Crossref
Corinne E. Fischer & Robert A. Sweet. (2016) Psychosis in Alzheimer’s Disease: a Review of Recent Research Findings. Current Behavioral Neuroscience Reports 3:4, pages 308-317.
Crossref
Crossref
Marco Onofrj, Astrid Thomas, Giovanni Martinotti, Francesca Anzellotti, Massimo Di Giannantonio, Fausta Ciccocioppo & Laura Bonanni. 2015. The Neuroscience of Visual Hallucinations. The Neuroscience of Visual Hallucinations
91
117
.
Niem Tu Huynh & Philippe Huot. (2014) Therapies under investigation for treating Parkinson's disease psychosis. Clinical Investigation 4:10, pages 889-901.
Crossref
Crossref
Jee-Young Lee, Jae Min Kim, Jeeyun Ahn, Han-Joon Kim, Beom S. Jeon & Tae Wan Kim. (2014) Retinal nerve fiber layer thickness and visual hallucinations in Parkinson's Disease. Movement Disorders 29:1, pages 61-67.
Crossref
Crossref
L. Bonanni, G. Bontempo, I. Borrelli, S. Bifolchetti, M. P. Buongarzone, N. Carlesi, A. Carolei, F. Ciccocioppo, U. Colangelo, G. Colonna, M. Desiderio, S. Ferretti, L. Fiorelli, O. D’Alessio, A. D’Amico, M. C. D’Amico, R. De Lucia, L. Del Re, F. Di Blasio, R. Di Giacomo, A. Di Iorio, E. Di Santo, M. Di Giuseppe, N. Felice, P. Litterio, A. Gabriele, E. Mancino, L. Manzoli, V. Maruotti, S. Mearelli, G. Molino, D. Monaco, F. Nuccetelli, M. Onofrj, B. Perfetti, C. Sacchet, F. Sensi, S. Sensi, P. Sucapane, J. P. Taylor, A. Thomas, P. Viola, S. Viola, M. Zito & H. Zhuzhuni. (2013) Ascertainment bias in dementias: a secondary to tertiary centre analysis in Central Italy and conceptual review. Aging Clinical and Experimental Research 25:3, pages 265-274.
Crossref
Crossref
Kurt A. Jellinger. (2012) Cerebral correlates of psychotic syndromes in neurodegenerative diseases. Journal of Cellular and Molecular Medicine 16:5, pages 995-1012.
Crossref
Crossref
Vincent Ries, Roland Selzer, Tobias Eichhorn, Wolfgang H. Oertel & Karla Eggert. (2010) Replacing a Dopamine Agonist by the COMT-Inhibitor Tolcapone as an Adjunct to l-dopa in the Treatment of Parkinson's Disease. Clinical Neuropharmacology 33:3, pages 142-150.
Crossref
Crossref
Ronald B. Postuma, Jean‐Francois Gagnon, Melanie Vendette & Jacques Y. Montplaisir. (2009) Idiopathic REM sleep behavior disorder in the transition to degenerative disease. Movement Disorders 24:15, pages 2225-2232.
Crossref
Crossref
Dag Aarsland, Laura Marsh & Anette Schrag. (2009) Neuropsychiatric symptoms in Parkinson's disease. Movement Disorders 24:15, pages 2175-2186.
Crossref
Crossref
Ufuk Ergün, Ayla Bozbaş, Ümit Akin & Levent İnan. (2009) Musical Hallucinations and Parkinson Disease. The Neurologist 15:3, pages 150-152.
Crossref
Crossref
Pietro Pietrini, Eric Salmon & Paolo Nichelli. 2009. The Neurology of Conciousness. The Neurology of Conciousness
203
215
.
Pietro Pietrini, Eric Salmon & Paolo Nichelli. 2009. The Neurology of Consciousness. The Neurology of Consciousness
204
216
.